Axogen, Inc. Cost of Goods Sold (Deprecated 2018-01-31)
Axogen, Inc. (AXGN) reported Cost of Goods Sold (Deprecated 2018-01-31) of $3.46 million for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-10-29.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-10-29
- Axogen, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-09-30 was $3.46M, a 38.32% increase year-over-year.
- Axogen, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $3.11M, a 36.40% increase year-over-year.
- Axogen, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $2.71M, a 41.59% increase year-over-year.
- Axogen, Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $2.61M, a 42.88% increase year-over-year.
- Axogen, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $9.31M, a 43.98% increase from fiscal 2016.
- Axogen, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $6.47M, a 33.39% increase from fiscal 2015.
- Axogen, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $4.85M, a 40.85% increase from fiscal 2014.
- Axogen, Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $3.44M, a 41.08% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-09-30 | $3.46M 10-Q · filed 2018-10-29 | $6.57M derived: sum of 2 quarters · filed 2018-10-29 | $9.28M 10-Q · filed 2018-10-29 | $11.90M derived: sum of 4 quarters · filed 2018-10-29 |
| 2018-06-30 | $3.11M 10-Q · filed 2018-08-01 | $5.82M 10-Q · filed 2018-08-01 | $8.43M derived: sum of 3 quarters · filed 2018-08-01 | $10.94M derived: sum of 4 quarters · filed 2018-10-29 |
| 2018-03-31 | $2.71M 10-Q · filed 2018-04-30 | $5.33M derived: sum of 2 quarters · filed 2018-04-30 | $7.83M derived: sum of 3 quarters · filed 2018-10-29 | $10.11M derived: sum of 4 quarters · filed 2018-10-29 |
| 2017-12-31 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $5.12M derived: sum of 2 quarters · filed 2018-10-29 | $7.40M derived: sum of 3 quarters · filed 2018-10-29 | $9.31M 10-K · filed 2018-02-28 |
| 2017-09-30 | $2.50M 10-Q · filed 2018-10-29 | $4.78M derived: sum of 2 quarters · filed 2018-10-29 | $6.70M 10-Q · filed 2018-10-29 | $8.53M derived: sum of 4 quarters · filed 2018-10-29 |
| 2017-06-30 | $2.28M 10-Q · filed 2018-08-01 | $4.19M 10-Q · filed 2018-08-01 | $6.02M derived: sum of 3 quarters · filed 2018-08-01 | $7.72M derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-03-31 | $1.92M 10-Q · filed 2018-04-30 | $3.75M derived: sum of 2 quarters · filed 2018-04-30 | $5.44M derived: sum of 3 quarters · filed 2018-04-30 | $6.98M derived: sum of 4 quarters · filed 2018-04-30 |
| 2016-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $3.53M derived: sum of 2 quarters · filed 2018-02-28 | $5.06M derived: sum of 3 quarters · filed 2018-02-28 | $6.47M 10-K · filed 2018-02-28 |
| 2016-09-30 | $1.70M 10-Q · filed 2017-11-01 | $3.23M derived: sum of 2 quarters · filed 2017-11-01 | $4.64M 10-Q · filed 2017-11-01 | $6.05M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $1.53M 10-Q · filed 2017-08-02 | $2.94M 10-Q · filed 2017-08-02 | $4.36M derived: sum of 3 quarters · filed 2018-02-28 | $5.77M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $1.41M 10-Q · filed 2017-05-04 | $2.82M derived: sum of 2 quarters · filed 2018-02-28 | $4.23M derived: sum of 3 quarters · filed 2018-02-28 | $5.27M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $2.83M derived: sum of 2 quarters · filed 2018-02-28 | $3.87M derived: sum of 3 quarters · filed 2018-02-28 | $4.85M 10-K · filed 2018-02-28 |
| 2015-09-30 | $1.41M 10-Q · filed 2016-11-02 | $2.45M derived: sum of 2 quarters · filed 2016-11-02 | $3.43M 10-Q · filed 2016-11-02 | $4.39M derived: sum of 4 quarters · filed 2016-11-02 |
| 2015-06-30 | $1.04M 10-Q · filed 2016-08-03 | $2.02M 10-Q · filed 2016-08-03 | $2.98M derived: sum of 3 quarters · filed 2016-08-03 | $3.88M derived: sum of 4 quarters · filed 2016-08-03 |
| 2015-03-31 | $982.88K 10-Q · filed 2016-05-04 | $1.94M derived: sum of 2 quarters · filed 2016-05-04 | $2.84M derived: sum of 3 quarters · filed 2016-05-04 | $3.72M derived: sum of 4 quarters · filed 2016-05-04 |
| 2014-12-31 | $956.88K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.85M derived: sum of 2 quarters · filed 2016-02-29 | $2.74M derived: sum of 3 quarters · filed 2016-02-29 | $3.44M 10-K · filed 2016-02-29 |
| 2014-09-30 | $896.18K 10-Q · filed 2015-11-05 | $1.78M derived: sum of 2 quarters · filed 2015-11-05 | $2.49M 10-Q · filed 2015-11-05 | $3.08M derived: sum of 4 quarters · filed 2015-11-05 |
| 2014-06-30 | $887.82K 10-Q · filed 2015-08-06 | $1.59M 10-Q · filed 2015-08-06 | $2.19M derived: sum of 3 quarters · filed 2015-08-06 | $2.84M derived: sum of 4 quarters · filed 2015-08-06 |
| 2014-03-31 | $701.30K 10-Q · filed 2015-05-05 | $1.30M derived: sum of 2 quarters · filed 2015-05-05 | $1.95M derived: sum of 3 quarters · filed 2015-05-05 | $2.58M derived: sum of 4 quarters · filed 2015-05-05 |
| 2013-12-31 | $596.07K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-05 | $1.25M derived: sum of 2 quarters · filed 2015-03-05 | $1.88M derived: sum of 3 quarters · filed 2015-03-05 | $2.44M 10-K · filed 2015-03-05 |
| 2013-09-30 | $650.21K 10-Q · filed 2014-11-13 | $1.28M derived: sum of 2 quarters · filed 2014-11-13 | $1.84M 10-Q · filed 2014-11-13 | $2.32M derived: sum of 4 quarters · filed 2014-11-13 |
| 2013-06-30 | $633.29K 10-Q · filed 2014-08-04 | $1.19M 10-Q · filed 2014-08-04 | $1.67M derived: sum of 3 quarters · filed 2014-08-04 | $2.21M derived: sum of 4 quarters · filed 2014-08-04 |
| 2013-03-31 | $560.24K 10-Q · filed 2014-04-30 | $1.04M derived: sum of 2 quarters · filed 2014-04-30 | $1.58M derived: sum of 3 quarters · filed 2014-04-30 | $2.08M derived: sum of 4 quarters · filed 2014-04-30 |
| 2012-12-31 | $478.57K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | $1.02M derived: sum of 2 quarters · filed 2014-03-06 | $1.52M derived: sum of 3 quarters · filed 2014-03-06 | $1.96M 10-K · filed 2014-03-06 |
| 2012-09-30 | $542.24K 10-Q · filed 2013-10-30 | $1.04M derived: sum of 2 quarters · filed 2013-10-30 | $1.48M 10-Q · filed 2013-10-30 | $2.02M derived: sum of 4 quarters · filed 2013-10-30 |
| 2012-06-30 | $501.92K 10-Q · filed 2013-08-14 | $941.08K 10-Q · filed 2013-08-14 | $1.47M derived: sum of 3 quarters · filed 2013-08-14 | $2.60M derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $439.16K 10-Q · filed 2013-04-30 | $972.29K derived: sum of 2 quarters · filed 2013-08-07 | $2.10M derived: sum of 3 quarters · filed 2013-08-07 | $2.53M derived: sum of 4 quarters · filed 2013-08-07 |
| 2011-12-31 | $533.13K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-07 | $1.66M derived: sum of 2 quarters · filed 2013-08-07 | $2.09M derived: sum of 3 quarters · filed 2013-08-07 | $2.43M 10-K/A · filed 2013-08-07 |
| 2011-09-30 | $1.13M 10-Q · filed 2012-11-06 | $1.55M derived: sum of 2 quarters · filed 2012-11-06 | $1.89M 10-Q · filed 2012-11-06 | $2.74M derived: sum of 4 quarters · filed 2012-11-06 |
| 2011-06-30 | $424.30K 10-Q · filed 2012-08-14 | $763.08K 10-Q · filed 2012-08-14 | $1.61M derived: sum of 3 quarters · filed 2012-08-14 | $1.77M derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $338.78K 10-Q · filed 2012-05-15 | $1.18M derived: sum of 2 quarters · filed 2012-05-15 | $1.34M derived: sum of 3 quarters · filed 2012-05-15 | |
| 2010-12-31 | $842.75K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | $1.00M derived: sum of 2 quarters · filed 2012-03-15 | $1.38M 10-K · filed 2012-03-15 | |
| 2010-09-30 | $160.77K 10-Q · filed 2011-11-14 | $536.18K 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |